Clinical Trial: Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940349) titled 'Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors' on April 08.

Brief Summary: The goal of this clinical trial is to learn if a combination of Palbociclib and Sunitinib is safe and effective in various solid tumors.

The main questions it aims to answer are:

* Is the drugs combination safe for the participants?

* Is the drug combination effective in all solid malignancies? It is a single arm study, phase 1b/2, dose escalation and expansion, to determine the safety, tolerability and initial efficacy of this combination.

Participants will:

* Take the drugs combina...